Drug shortages plague hematology, but preparedness helpsJuly 18, 2022CLLALLHodgkin LymphomaMixed TopicsBusiness of MedicineB Cell LymphomaMantle Cell Lymphoma
FDA approves liso-cel as second-line therapy for LBCLJune 27, 2022B Cell LymphomaMixed TopicsCellular TherapyGene TherapyCLL
Novel gene therapy offers hope for some lymphomasJune 9, 2022B Cell LymphomaGene TherapyTransplantMixed Topics
‘Exciting’ new gene therapy yields promising resultsJune 5, 2022Gene TherapyIndolent LymphomaB Cell Lymphoma
Third-generation Black woman physician makes cancer research historyMay 24, 2022Mixed TopicsALLB Cell LymphomaHodgkin LymphomaMantle Cell LymphomaDiversity in MedicineAML
Ex–hospital porter a neglected giant of cancer researchMay 11, 2022ALLAggressive LymphomasB Cell LymphomaCLLDLBCLMantle Cell LymphomaMultiple Myeloma
Repurposed drug could revolutionize stem cell transplantationMarch 18, 2022TransplantB Cell LymphomaHodgkin LymphomaMultiple MyelomaPediatricsDLBCLCLL
100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'January 21, 2022TransplantAggressive LymphomasALLDLBCLCLLTranslational ResearchB Cell Lymphoma
Rituximab and COVID-19 vaccines: Studies begin to answer key questionsJanuary 21, 2022COVID-19 UpdatesCLLB Cell LymphomaDLBCL
DKMS: Small nonprofit to world’s largest stem cell donor registryJanuary 21, 2022ALLCOVID-19 UpdatesMixed TopicsMultiple MyelomaDLBCLB Cell LymphomaAML
